Parity, early menopause and the incidence of bladder cancer in women: a case-control study and meta-analysis
- PMID: 21067913
- PMCID: PMC3042804
- DOI: 10.1016/j.ejca.2010.10.007
Parity, early menopause and the incidence of bladder cancer in women: a case-control study and meta-analysis
Abstract
Introduction: Incidence rates of bladder cancer are notably higher in men than in women. While there is evidence that reproductive and hormonal risk factors may influence risk of bladder cancer, data are inconclusive.
Materials and methods: We examined reproductive, menstrual and hormonal use history in our population-based case-control study of bladder cancer in New Hampshire (NH), USA (n=207 women cases and n=463 women controls). Additionally, we performed a meta-analysis of the published literature. We used unconditional logistic regression analysis to compute adjusted odds ratios associated with each risk factor in the NH study. We combined these estimates with those from the published literature using inverse variance effects models.
Results: In the NH study, a slightly decreased odds ratio was found among women who had ever had a birth compared to nulliparous women and an elevated odds ratio among women who underwent surgical menopause (bilateral oophorectomy), especially at an early age. No overall associations were found with oral contraceptive use or hormone replacement therapy. These findings were generally in agreement with the meta-analytic results for which the combined relative risk (RR) estimate was reduced among ever parous women (combined RR estimate for ever parous versus nulliparous=0.66, 95% confidence intervals [95% CI] 0.55-0.79) and elevated among those undergoing an early menopause (combined RR estimate for early versus late menopause=1.59, 95% CI 1.31-1.92). No consistent risk was observed for the other factors.
Discussion: Some reproductive and menstrual factors appear to be related to the incidence of bladder cancer among women; but whether effects are due to female hormones is uncertain.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Figures


Similar articles
-
Early menarche, nulliparity and the risk for premature and early natural menopause.Hum Reprod. 2017 Mar 1;32(3):679-686. doi: 10.1093/humrep/dew350. Hum Reprod. 2017. PMID: 28119483 Free PMC article.
-
Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology.Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1156-70. doi: 10.1158/1055-9965.EPI-11-0017. Epub 2011 Apr 14. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21493870 Free PMC article.
-
Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study.Int J Cancer. 2006 Nov 15;119(10):2398-401. doi: 10.1002/ijc.22175. Int J Cancer. 2006. PMID: 16894568
-
Reproductive factors and thyroid cancer risk: Meta-analysis.Head Neck. 2019 Dec;41(12):4199-4208. doi: 10.1002/hed.25945. Epub 2019 Oct 8. Head Neck. 2019. PMID: 31595581
-
Reproductive factors and risk of Parkinson's disease in women: A meta-analysis of observational studies.Behav Brain Res. 2017 Sep 29;335:103-110. doi: 10.1016/j.bbr.2017.07.025. Epub 2017 Jul 22. Behav Brain Res. 2017. PMID: 28743601 Review.
Cited by
-
The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histology.Oncol Lett. 2018 Aug;16(2):1641-1649. doi: 10.3892/ol.2018.8837. Epub 2018 May 30. Oncol Lett. 2018. PMID: 30008848 Free PMC article.
-
Differential expression of cytokeratin 14 and 18 in bladder cancer tumorigenesis.Exp Biol Med (Maywood). 2018 Feb;243(4):344-349. doi: 10.1177/1535370218754493. Epub 2018 Jan 19. Exp Biol Med (Maywood). 2018. PMID: 29350066 Free PMC article.
-
The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women.Cancer Causes Control. 2020 May;31(5):503-510. doi: 10.1007/s10552-020-01294-0. Epub 2020 Mar 19. Cancer Causes Control. 2020. PMID: 32193704 Free PMC article.
-
Age-specific effect of gender on upper tract urothelial carcinoma outcomes.Med Oncol. 2013;30(3):640. doi: 10.1007/s12032-013-0640-6. Epub 2013 Jun 19. Med Oncol. 2013. PMID: 23780658
-
Role of oestrogen receptors in bladder cancer development.Nat Rev Urol. 2013 Jun;10(6):317-26. doi: 10.1038/nrurol.2013.53. Epub 2013 Apr 16. Nat Rev Urol. 2013. PMID: 23588401 Review.
References
-
- Kogevinas M, Trichopoulos D. Urinary Bladder Cancer. In: Adami H-O, Hunter D, Trichopoulos D, editors. Textbook of Cancer Epidemiology. Oxford University Press; New York: 2008. pp. 446–466.
-
- McGrath M, Michaud D, Vivo ID. Hormonal and Reproductive Factors and the Risk of Bladder Cancer in Women. Am J Epidemiol. 2006;163(3):236–244. - PubMed
-
- Scosyrev E, Noyes K, Feng C, Messing E. Sex and Racial Differences in Bladder Cancer Presentation and Mortality in the US. Cancer. 2009;115:68–74. - PubMed
-
- Karim-Kos H, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh J. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44:1345–1389. - PubMed
-
- Cantor K, Lynch C, Johnson D. Bladder cancer, parity, and age at first birth. Cancer Causes Control. 1992;3:57–62. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical